510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K160090Substantially Equivalent

Lumipulse G ROMA

Fujirebio Diagnostics, Inc., Malvern PA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K160090 is the FDA 510(k) clearance record for Lumipulse G ROMA, a class II device, cleared for Fujirebio Diagnostics,Inc. on under FDA product code ONX (Ovarian Adnexal Mass Assessment Score Test System). FDA's definition for product code ONX reads: "An ovarian/adnexal mass assessment test is a devicem that measures one or more proteins in serum. It yields a single result for the likelihood that an adnexal pelvic mass in a woman, for whom surgery is planned, is malignant. The test isn...". FDA records list 45 510(k) clearances for Fujirebio Diagnostics,Inc., from to . As of , FDA records show no recalls naming K160090.

Clearance record

Decision date
Received
(122 days to decision)
Product code
ONX Ovarian Adnexal Mass Assessment Score Test System
Regulation
21 CFR 866.6050
Device class
Class II
Review panel
Obstetrics/Gynecology
Applicant
Fujirebio Diagnostics,Inc. 201 Great Valley Pkwy., Malvern PA
510(k) summary
Summary PDF
Third party review
No

Clearances, product code ONX

Trailing 12 months

FDA records hold no clearances under product code ONX in the trailing twelve months.

FDA records show no clearances under product code ONX in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code ONX, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260